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HIGHLIGHTS 
 
 Coumarin (2H-benzopyran-2-one) derivatives with amino, phenyl, 4-methoxyphenyl 
and styryl groups at the 7-position, were synthesized and used in the derivatization of 
glycine and β-alanine. 
 
 The new ester cages of glycine and β-alanine, selected as models of carboxylic acid 
bioactive molecules, revealed to be interesting photo-responsive units.  
 
 A remarkable behaviour towards irradiation at higher wavelength (350 and 419 nm) 
occurred in conjugates obtained from 4-(chloromethyl)-7-styryl-2H-benzopyran-2-
one. 
 
 Time-resolved fluorescence studies complemented the photolysis results and 
proposed mechanism revealing the presence of different fluorescing species by the 
determination of decay associated spectra. 
 
 This study shows new promising alternative moieties for the development of 
photoactivable fluorescent acid prodrugs.   
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Abstract: New ester cages bearing the coumarin (2H-benzopyran-2-one) skeleton with extended π-
systems as phototriggers, for glycine and β-alanine, as models of carboxylic acid bifunctional 
molecules with biological relevance, were evaluated under photolysis conditions at 254, 300, 350 
and 419 nm of irradiation in a RPR-100 photochemical reactor. The processes were followed by 
HPLC-UV detection and 
1
H NMR with collection of kinetic data. The results showed a correlation 
between the photolysis efficiency and the increasing extension of the conjugation for both glycine 
and β-alanine, showing that the 7-aminocoumarin afforded the best results at all wavelengths tested.    
From a study of the time-resolved fluorescence behaviour, these compounds were also found to 
exhibit more complex fluorescence decay kinetics. This was attributed to the presence of conjugated 
and non-conjugated coumarin species.  
 
Keywords: Phototriggers; Caging groups; Neurotransmitters; Coumarins; Photolysis. 
 
 
1. Introduction 
2H-Benzopyran-2-one, the IUPAC name of coumarin, is an oxygen heterocycle firstly isolated in 
1820 by Voleg from the plant Dypteryx adorata and is at the moment known to be present in a huge 
number of natural products [1-3]. Since ancient Egyptian times, coumarins have been known for 
their therapeutic properties, namely anticancer, antimicrobial, anesthetic, anti-HIV, anticoagulant 
and antioxidant activities. Also, coumarins are used in the cosmetic and food industries, as 
fluorescent probes and, more recently, as photocleavable protecting groups (PPGs) [4-9]. 
PPGs are chemical entities used to temporarily disable the activity of a compound, which is 
achieved by a covalent bond between the PPG and a functional group essential to its activity. After 
irradiation, the bond is cleaved and the compound activity is restored. For a biological application, 
the employed wavelength needs to be as near as possible to the visible radiation wavelength in 
order to reduce cellular damage. PPGs can be used to synthesize prodrugs sensitive to light, 
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producing inactive therapeutic agents that regain their biological activity after irradiation. These 
prodrugs allow the controlled release of drugs; both in time and locally, thus holding the promise of 
reduced side effects and toxicity [10-15].  
In comparison to one of the most common PPGs, o-nitrobenzyl, coumarins possess higher molar 
extinction coefficients at longer wavelengths, higher releasing rates, increased stability and good 
fluorescence. This makes them excellent options as PPGs for biological applications, besides their 
interest for organic synthesis, and the study of their fluorescence provides a means by which to 
assess the photocleavage process [11,16,17]. In addition, some coumarins can be used in two-
photon uncaging, a process where two photons are simultaneous absorbed and provide the 
excitation energy required to initiate the photophysical process. This technique enables photolysis 
by the absorption of NIR radiation which is less toxic to living systems than UV and presents a 
higher tissue penetrating capacity [11-18]. Coumarins have been used in the photorelease of several 
bioactive compounds such as amino acids (glycine, -alanine, GABA, glutamate), secondary 
messengers (cGMP, cAMP, diacylglycerol), nucleic acids/oligonucleotides (DNA, mRNA, 8-
bromonucleotids, ATP, ADP, AMP), hormones (progesterone), cholesterol and even drugs 
(anisomycin and paclitaxel) [19-29]. 
Considering that one of the major drawbacks of PPGs is the fact that their maximum absorption 
wavelength is at shorter wavelengths, the present work describes the synthesis of a new set of ester 
conjugates of coumarins possessing an extended π-system or an amino group at position 7 of the 
system. The intention is to bathochromically shift the wavelength of maximum absorption, and 
consequently, of photolysis. Glycine and β-alanine were used as models of carboxylic acids, which 
besides representing bifunctional molecules used in organic synthesis, possess crucial biological 
roles in humans (as neurotransmitters, for example) [40-42]. 
For this purpose, the caged amino acids were characterized (using UV-Vis and fluorescence 
spectroscopy) and irradiated at 254, 300, 350 and 419 nm in a photochemical reactor Rayonet RPR-
100. The release of the active compound was monitored by HPLC-UV detection with collection of 
kinetic data and also by 
1
H NMR. 
 
 
2. Experimental Section 
 
2.1. Material and instruments 
All melting points were measured on a Stuart SMP3 melting point apparatus. TLC analyses were 
carried out on 0.25 mm thick precoated silica plates (Merck Fertigplatten Kieselgel 60F254) and 
spots were visualised under UV light. Chromatography on silica gel was carried out on Merck 
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Kieselgel (230-240 mesh). IR spectra were determined on a BOMEM MB 104 spectrophotometer 
using KBr discs. UV/visible absorption spectra (200 – 700 nm) were obtained using a Shimadzu 
UV/2501PC spectrophotometer. NMR spectra were obtained on a Bruker Avance III 400 at an 
operating frequency of 400 MHz for 
1
H and 100.6 MHz for 
13
C using the solvent peak as internal 
reference at 25 ºC. All chemical shifts are given in ppm using δH Me4Si = 0 ppm as reference and J 
values are given in Hz. Assignments were supported by spin decoupling-double resonance and 
bidimensional heteronuclear correlation techniques.  Mass spectrometry analyses were performed at 
the “C.A.C.T.I. - Unidad de Espectrometria de Masas”, at University of Vigo, Spain. Fluorescence 
spectra were collected using a FluoroMax-4 spectrofluorometer and excitation – emission matrices 
(EEM’s) were recorded using a FluoroLog 3. Time-resolved fluorescence was measured using a 
HORIBA Scientific DeltaFlex equipped with a DeltaDiode (DD-350, emitting at 349 nm) excitation 
source. Fluorescence decays were measured at 5 nm increments over the wavelength range 375 nm 
to 575 nm. The resultant decays were analysed globally to obtain decay associated spectra (using 
EzTime software) or just made use of the decay obtained at 480 nm in the dataset. During the 
analysis, an “extra” short-lived component (not plotted in Figure 3) was required and attributed to 
scattered excitation. The optical density of the samples used or these fluorescence measurements 
was kept to ~0.1 to avoid self-absorption effects. Photolysis measurements were carried out using a 
Rayonet RPR-100 chamber reactor equipped with 10 lamps of 254, 300, 350 and 419 ± 10 nm. 
HPLC analyses were performed using a Licrospher 100 RP18 (5 μm) column in a JASCO HPLC 
system composed by a PU-2080 pump and a UV-2070 detector with ChromNav software. All 
reagents were used as received. The synthesis of chloromethyl precursors 1a-e is included in the 
supporting information. 
 
2.2. General procedure for the synthesis of conjugates 4 and 5. 
The chloromethyl precursors 1a-e were dissolved in dry DMF (3 mL), and potassium fluoride (3 
equiv) and N-(tert-butoxycarbonyl)-glycine or N-(tert-butoxycarbonyl)-β-alanine (1 equiv) were 
added.  The reaction mixture was stirred at room temperature for 24 h.  The solvent was removed by 
evaporation under reduced pressure and the required conjugate was obtained as a solid. The crude 
residue of compounds 4 and 5 was purified by column chromatography using mixtures of increasing 
polarity of dichloromethane/methanol (4a-e) or light petroleum/ethyl acetate (5a-e) as eluent. 
 
2.2.1. N-(tert-Butyloxycarbonyl)-glycine (2-oxo-2H-benzopyran-4-yl)methyl ester 4a. Starting from 
compound 1a (0.031 g, 1.6 × 10
-4
 mol) in dry DMF (2 mL), potassium fluoride (0.028 g, 4.8 × 10
-4
 
mol) and N-(tert-butoxycarbonyl)-glycine 2 (0.028 g, 1.6 × 10
-4
 mol), the ester conjugate 4a was 
obtained as an orange solid (0.031 g, 56%). Mp = 115.1-116.6 ºC. Rf = 0.67 (dichloromethane). 
1
H 
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NMR (CDCl3, 400 MHz): δ = 1.47 (s, 9 H, C(CH3)3), 4.07 (d, J 5.6 Hz, 2 H, H-α),  4.98 ( br s, 1 H, 
NH), 5.39 (s, 2 H, CH2), 6.51 (s, 1 H, H-3), 7.33 (td, J 8 and 1.2 Hz, 1 H, H-6), 7.39 (dd, J 8 and 0.8 
Hz, 1 H, H-8), 7.52 (dd, J 8 and 1.6 Hz, 1 H, H-5), 7.58 (td, J 8.8 and 1.6 Hz, 1 H, H-7) ppm. 
13
C 
NMR (CDCl3, 100.6 MHz): δ = 28.27 (C(CH3)3) 42.41 (C-α), 61.78 (CH2), 80.45 (C(CH3)3)), 
113.67 (C-3), 116.99 (C-4a), 117.50 (C-8), 123.41 (C-5), 124.55 (C-6), 132.22 (C-7), 148.25 (C-4), 
153.66 (C-8a), 155.70 (C=O Boc), 160.16 (C-2), 169.77 (C=O Gly) ppm. IR (liquid film): ν = 3440, 
3058, 2980, 2918, 2850, 1729, 1630, 1608, 1569, 1510, 1452, 1407, 1368, 1266, 1162, 1070, 1006, 
937, 862, 738, 703 cm
-1
. HRMS: m/z (ESI): Found [M++1]: 334.12910; C17H20NO6 requires [M
+
+1]: 
334.12925. 
 
2.2.2. N-(tert-Butyloxycarbonyl)-glycine (7-amino-2-oxo-2H-benzopyran-4-yl)methyl ester 4b. 
Starting from compound 1b (0.031 g, 1.6 × 10
-4
 mol) in dry DMF (2 mL), potassium fluoride (0.016 
g, 8.0 × 10
-5
 mol) and N-(tert-butoxycarbonyl)-glycine 2 (0.028 g, 1.6 × 10
-4
 mol), the ester 
conjugate 4b was obtained as an yellow solid (0.038 g, 70%). Mp = 179.6-180.2 ºC. Rf = 0.6 
(dichloromethane/methanol 20:1). 
1
H NMR (DMSO-d6, 400 MHz): δ = 1.38 (s, 9 H, C(CH3)3), 3.83 
(d, J 6 Hz, 2 H, H-α), 5.30 (s, 2 H, CH2), 6.00 (s, 1 H, H-3), 6.72 (s, 2 H, NH2), 6.42 (d, J 2 Hz, H-
8), 6.55 (dd, J 8.8 and 2 Hz, 1 H, H-6), 7.31-7.36 (m, 2 H, H-5 and NH) ppm. 
13
C NMR (DMSO-
d6, 100.6 MHz): δ = 28.12 (C(CH3)3), 42.05 (C-α), 61.43 (CH2), 78.40 (C(CH3)3), 98.58 (C-8), 
104.65 (C-3), 105.70 (C-4a), 111.31 (C-6), 125.41 (C-5), 150.56 (C-4), 153.25 (C-8a), 155.57 (C-
7), 155.94 (C=O Boc), 160.54 (C-2), 170.03 (C=O Gly) ppm. IR (KBr 1%): ν = 3383, 3231, 2976, 
2363, 1743, 1702, 1616, 1526, 1404, 1279, 1169, 1056, 869, 850, 819, 747 cm
-1
. HRMS: m/z (ESI): 
Found [M
+ 
+1]: 349.14003; C17H21N2O6 requires [M
+
+1]: 349.14010. 
 
2.2.3. N-(tert-Butyloxycarbonyl)-glycine (7-phenyl-2-oxo-2H-benzopyran-4-yl)methyl ester 4c. 
Starting from compound 1c (0.037 g, 1.4 × 10
-4
 mol) in dry DMF (2 mL), potassium fluoride (0.025 
g, 4.3 × 10
-3
 mol) and N-(tert-butoxycarbonyl)-glycine 2 (0.025 g, 1.4 × 10
-5
 mol), the ester 
conjugate 4c was obtained as an yellow solid (0.009 g, 16%). Mp = 129.5-131.6 ºC. Rf = 0.55 
(dichloromethane/methanol 100:1). 
1
H NMR (CDCl3, 400 MHz): δ = 1.46 (s, 9 H, C(CH3)3), 4.08 
(d, J 5 Hz, 2 H, H-α), 5.07 (t, J 5 Hz 1 H, NH), 5.41 (s, 2 H, CH2), 6.51 (s, 1 H, H-3), 7.45 (tt, J 7.2 
and 1.2 Hz, 1 H, H-4’), 7.51 (tt, J 7.2 and 1.2 Hz, 2 H, H-3’and H-5’), 7.57-7.60 (m, 3 H, H-5, H-6 
and H-8), 7.64 (dt, J 7.2 and 1.2 Hz, 2 H, H-2’ and H-6’) ppm. 13C NMR  (CDCl3, 100.6 MHz): δ = 
28.27 (C(CH3)3), 42.41 (C-α), 61.81 (CH2), 80.46 (C(CH3)3), 113.27 (C-3), 115.51 (C-6), 115.86 
(C-4a), 123.38 (C-8), 123.79 (C-5), 127.19 (C-2’ and C-6’), 128.71 (C-4’), 129.14 (C-3’ and C-5’), 
138.81 (C-1’), 145.41 (C-7), 148.13 (C-4), 154.10 (C-8a), 155.71 (C=O Boc), 160.31 (C-2), 169.78 
(C=O Gly) ppm. IR (liquid film): ν = 3371, 3061, 2978, 2932, 1722, 1617, 1583, 1514, 1452, 1406, 
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1368, 1337, 1279, 1252, 1163, 1074, 1055, 1004, 952, 866, 766, 750, 737, 699   cm
-1
. HRMS: m/z 
(ESI): Found [M
+ 
+1]: 410.16042; C23H24NO6 requires [M
+
+1]: 410.16037. 
 
2.2.4. N-(tert-Butyloxycarbonyl)-glycine [7-(4’methoxyphenyl)-2-oxo-2H-benzopyran-4-yl]methyl 
ester 4d. Starting from compound 1d (0.037 g, 1.4 × 10
-4
 mol) in dry DMF (2 mL), potassium 
fluoride (0.013 g, 2.2 × 10
-4
 mol) and N-(tert-butoxycarbonyl)-glycine 2 (0.013 g, 7.0 × 10
-5
 mol), 
the ester conjugate 4d was obtained as a beige solid (0.008 g, 25%). Mp = 142.4-143.7 ºC. Rf = 0.4 
(dichloromethane / methanol 100:1). 
1
H NMR (CDCl3, 400 MHz): δ = 1.46 (s, 9 H, C(CH3)3), 3.87 
(s, 3 H, OCH3), 4.07 (d, J 6 Hz, 2 H, H-α), 5.12 (br s, 1H, NH), 5.37 (s, 2 H, CH2), 6.46 (s, 1 H, H-
3), 7.01 (dt, J 6.8 and 2 Hz, 2 H, H-3’ and H-5’), 7.51-7.52 (m, 3 H, H-5, H-6 and H-8), 7.57 (dt, J 
6.8 and 2 Hz, 2 H, H-2’ and H-6’) ppm. 13C NMR (CDCl3, 100.6 MHz): δ = 28.25 (C(CH3)3), 42.40 
(C-α), 55.38 (OCH3), 61.79 (CH2), 79.03 (C(CH3)), 112.77 (C-3), 114.55 (C-3’ and C-5’), 114.70 
(C-6), 115.27 (C-4a), 122.81 (C-8), 123.71 (C-5), 128.29 (C-2’ and C-6’), 131.09 (C-1’), 144.94 
(C-7), 148.19 (C-4), 154.14 (C-8a), 155.72 (C=O Boc) 160.24 (C-4’), 160.40 (C-2), 169.78 (C=O 
Gly) ppm. IR (liquid film): ν = 3370, 3057, 2975, 2921, 2850, 1721, 1609, 1579, 1526, 1502, 1458, 
1406, 1368, 1337, 1300, 1281, 1253, 1163, 1074, 1028, 952, 866, 839, 816, 735, 703 cm
-1
. HRMS: 
m/z (ESI): Found [M
+ 
+1]: 440.17098; C24H26NO7 requires [M
+
+1]: 440.17099. 
 
2.2.5. N-(tert-Butyloxycarbonyl)-glycine (7-styryl-2-oxo-2H-benzopyran-4-yl)methyl ester 4e. 
Starting from compound 1e (0.027 g, 9.0 × 10
-5 
mol) in dry DMF (2 mL), potassium fluoride (0.016 
g, 2.7 × 10
-4
 mol) and N-(tert-butoxycarbonyl)-glycine 2 (0.016 g, 9.0 × 10
-5
 mol), the ester 
conjugate 4d was obtained as a yellow solid (0.023 g, 58%). Mp = 131.3-131.4 ºC. Rf = 0.38 
(dichloromethane/methanol 100:1). 
1
H NMR (CDCl3, 400 MHz): δ = 1.47 (s, 9H, C(CH3)3), 4.07 (d, 
J 6.4 Hz, 2 H, H-α), 5.07 (d, J 6.4 Hz , 1 H, NH), 5.37 (s, 2 H, CH2), 6.46 (s, 1 H, H-3), 7.12 (d, J 
16.4 Hz, 1 H, H-a), 7.25 (d, J 16.4 Hz, 1 H, H-b),  7.33 (tt, J 7.2 and 1.6 Hz, 1 H, H-4’), 7.40 (tt, J 
7.2 and 1.6 Hz, 1 H, H-3´and H-5’), 7.45-7.49 (m, 3 H, H-5, H-6 and H-8), 7.60 (dt, J 7.2 and 1.6 
Hz, 2 H, H-2’ and H-6’) ppm. 13C NMR (CDCl3, 100.6 MHz): δ = 28.27 (C(CH3)3), 42.41 (C-α), 
61.78 (CH2), 80.43 (C(CH3)), 112.91 (C-3), 114.62 (C-6), 116.04 (C-4a), 122.63 (C-8), 123.63 (C-
5), 126.54 (C-a), 126.93 (C-2’ and C-6’), 128.62 (C-4’), 128.84 (C-3’ and C-5’), 132.33 (C-b), 
136.27 (C-1’), 141.73 (C-7), 148.05 (C-4), 154.15 (C-8a), 155.71 (C=O Boc), 160.31 (C-2), 171.61 
(C=O Gly) ppm. IR (liquid film): ν = 3368, 2976, 2932, 1722, 1609, 1526, 1407, 1367, 1253, 1168, 
1083, 1027, 955, 866, 838, 815, 734 cm
-1
. HRMS: m/z (ESI): Found [M++1]: 436.17608; C21H19N2O5 
requires [M
+
+1]: 436.17605. 
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2.2.6. N-(tert-Butyloxycarbonyl)-β-alanine (2-oxo-2H-benzopyran-4-yl)methyl ester 5a. Starting 
from compound 1a (0.016 g, 8.0 × 10
-5 
mol) in dry DMF (2 mL), potassium fluoride (0.017 g, 2.5 × 
10
-4
 mol) and N-(tert-butoxycarbonyl)-β-alanine 3 (0.016 g, 8.0 × 10-5 mol), the ester conjugate 5a 
was obtained as an orange solid (0.011 g, 38%). Mp = 91.4-92.1 ºC. Rf = 0.5 (dichloromethane). 
1
H 
NMR (CDCl3, 400 MHz): δ = 1.45 (s, 9 H, C(CH3)3)), 2.70 (t, J 6 Hz, 2 H, H-α), 3.47 (q, J 6 Hz, 2 
H, H-β), 4.98 (br s, 1 H, NH), 5.34 (s, 2 H, CH2), 6.49 (s, 1 H, H-3), 7.33 (td, J 7.2 and 1.2 Hz, 1 H, 
H-6), 7.39 (dd, J 8.4 and 0.8 Hz, 1 H, H-8), 7.53 (dd, J 8.4 and 1.6 Hz, 1 H, H-5), 7.58 (td, J 7.2 and 
1.2 Hz, 1 H, H-7) ppm. 
13
C NMR (CDCl3, 100.6 MHz): δ = 28.34 (C(CH3)3), 34.55 (C-α), 36.05 (C-
β), 61.30 (CH2), 79.66 (C(CH3)3), 113.53 (C-3), 117.07 (C-4a), 117.49 (C-8), 123.41 (C-5), 124.52 
(C-6), 132.18 (C-7), 148.66 (C-4), 153.65 (C-8a), 155.72 (C=O Boc), 160.24 (C-2), 171.62 (C=O β-
Ala) ppm. IR (liquid film): ν = 3374, 2979, 2932, 1730, 1630, 1607, 1568, 1513, 1452, 1393, 1367, 
1318, 1252, 1170, 1082, 934, 860, 737, 704 cm
-1
. HRMS: m/z (ESI): Found [M++1]: 348.14476; 
C18H22NO6 requires [M
+
+1]: 348.14480. 
 
2.2.7. N-(tert-Butyloxycarbonyl)-β-alanine (7-amino-2-oxo-2H-benzopyran-4-yl)methyl ester 5b. 
Starting from compound 1b (0.030 g, 1.4 × 10
-4
 mol) in dry DMF (2 mL), potassium fluoride (0.025 
g, 4.3 × 10
-3
 mol) and N-(tert-butoxycarbonyl)-β-alanine 3 (0.027 g, 1.4 × 10-3 mol), the ester 
conjugate 5b was obtained as a beige solid (0.032 g, 65%). Mp = 157.3-158.2 ºC. Rf = 0.54 
(dichloromethane/methanol 20:1). 
1
H NMR (DMSO-d6, 400 MHz): δ = 1.36 (s, 9 H, C(CH3)3), 2.58 
(t, J 6 Hz, 2 H, H-α), 3.20 (q, J 6 Hz, 2 H, H-β), 5.22 (s, 1 H, CH2), 5.74 (s, 1 H, H-3), 6.18 (s, 2 H, 
NH2), 6.44 (d, J 2 Hz, 1 H, H-8), 6.55 (dd, J 8.4 and 2 Hz, 1 H, H-6), 6.90 (t, J 6 Hz, 1 H, NH), 7.35 
(d, J 8.8 Hz, 1 H, H-5) ppm. 
13
C NMR (DMSO-d6, 100.6 MHz): δ = 28.17 (C(CH3)3), 34.00 (C-α), 
36.05 (C-β), 61.27 (CH2), 77.77 (C(CH3)3), 98.60 (C-8), 105.02 (C-3), 105.84 (C-4a), 111.35 (C-6), 
125.47 (C-5), 150.63 (C-4), 153.25 (C-8a), 155.50 (C-7), 155.61 (C=O Boc), 160.56 (C-2), 170.83 
(C=O β-Ala) ppm. IR (KBr 1%): ν = 3485, 3393, 3349, 3227, 2972, 1748, 1707, 1682, 1643, 1608, 
1527, 1448, 1411, 1367, 1325, 1293, 1248, 1186, 857, 844, 806, 781, 746, 708 cm
-1
. HRMS: m/z 
(ESI): Found [M
+
+1]: 363.15569; C18H23N2O6 requires [M
+
+1]: 363.15559. 
 
2.2.8. N-(tert-Butyloxycarbonyl)-β-alanine (7-phenyl-2-oxo-2H-benzopyran-4-yl)methyl ester 5c. 
Starting from compound 1c (0.031 g, 1.2 × 10
-4
 mol) in dry DMF (2 mL), potassium fluoride (0.021 
g, 3.6 × 10
-3
 mol) and N-(tert-butoxycarbonyl)-β-alanine 3 (0.023 g, 1.2 × 10-5 mol), the ester 
conjugate 5c was obtained as a beige solid (0.028 g, 55%). Mp = 152.3-153.1 ºC. Rf = 0.61 
(dichloromethane / methanol 100:1). 
1
H NMR (CDCl3, 400 MHz): δ = 1.45 (s, 9 H, C(CH3)3), 2.71 
(m, 2 H, H-α), 3.47 (m, 2 H, H-β), 5.01 (br s, 1 H, NH), 5.59 (s, 2 H, CH2), 6.49 (s, 1 H, H-3), 7.43 
(tt, J 7.2 and 1.2 Hz, 1 H, H-4’), 7.50 (tt, J 7.2 and 1.2 Hz, 2 H, H-3’ and H-5’), 7.54-7.59 (m, 3 H, 
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H-5, H-6 and H-8), 7.63 (dt, J 7.2 and 1.2 Hz, 2 H, H-2’ and H-6’) ppm. 13C NMR (CDCl3, 100.6 
MHz): δ = 28.32 (C(CH3)3), 34.54 (C-α), 36.03 (C-β), 61.30 (CH2), 79.62 (C(CH3)3), 113.11 (C-3), 
115.44 (C-6), 115.93 (C-4a), 123.32 (C-8), 123.78 (C-5), 127.15 (C-2’ and C-6’), 128.67 (C-4’), 
129.10 (C-3’ and C-5’), 138.78 (C-1’), 145.32 (C-7), 148.52 (C-4), 154.07 (C-8a), 155.72 (C=O 
Boc) 160.35 (C-2), 171.61 (C=O β-Ala) ppm. IR (liquid film): ν = 3434, 3334, 3078, 2976, 2929, 
1743, 1713, 1618, 1546, 1500, 1438, 1409, 1366, 1327, 1246, 1167, 1092, 1066, 1042, 997, 962, 
868, 837, 764, 748, 707, 689 cm
-1
. HRMS: m/z (ESI): Found [M++1]: 424.17608; C24H26NO6 requires 
[M
+
+1]: 424.17611. 
 
2.2.9. N-(tert-Butyloxycarbonyl)-β-alanine [7-(4’methoxyphenyl)-2-oxo-2H-benzopyran-4-yl] 
methyl ester 5d. Starting from compound 1d (0.023 g, 1.2 × 10
-4
 mol) in dry DMF (2 mL), 
potassium fluoride (0.021 g, 3.6 × 10
-3
 mol) and N-(tert-butoxycarbonyl)-β-alanine 3 (0.023 g, 1.2 × 
10
-5
 mol), the ester conjugate 5c was obtained as a beige solid (0.028 g, 51%). Mp = 126.9-127.5 
ºC. Rf = 0.46 (dichloromethane/methanol 100:1). 
1
H NMR (CDCl3, 400 MHz): δ = 1.45 (s, 9 H, 
C(CH3)3), 2.71 (t, J 6 Hz, 2 H, H-α), 3.47 (q, J 6 Hz, 2 H, H-β), 3.88 (s, 3 H, OCH3), 4.99 (br s, 1 H, 
NH), 5.35 (s, 2 H, CH2) 6.46 (s, 1 H, H-3), 7.03 (dt, J 8.8 and 2 Hz, 2 H, H-3’ and H-5’), 7.50-7.56 
(m, 3 H, H-5, H-6 and H-8), 7.58 (dt, J 8,8 and 2 Hz, 2 H, H-2’ and H-6’) ppm. 13C NMR (CDCl3, 
100.6 MHz): δ = 28.35 (C(CH3)3), 34.56 (C-α), 36.05 (C-β), 55.41 (OCH3), 61.34 (CH2), 79.63 
(C(CH3)3), 112.74 (C-3), 114.58 (C-3’ and C-5’), 114.76 (C-6), 115.39 (C-4a), 122.82 (C-8), 
123.72 (C-5), 128.32 (C-2’ and C-6’), 131.15 (C-1’), 144.96 (C-7), 148.57 (C-4), 154.18 (C-8a), 
155.73 (C=O Boc), 160.26 (C-4’), 160.49 (C-2), 171.65 (C=O β-Ala) ppm. IR (liquid film): ν = 
3368, 3056, 2977, 2934, 2840, 2050, 1722, 1610, 1580, 1526, 1444, 1407, 1367, 1302, 1279, 1253, 
1170, 1083, 1028, 996, 955, 866, 839, 816,781, 735, 704 cm
-1
. HRMS: m/z (ESI): Found [M++1]: 
454.18664; C25H28NO7 requires [M
+
+1]: 454.18652. 
 
2.2.10. N-(tert-Butyloxycarbonyl)-β-alanine (7-styryl-2-oxo-2H-benzopyran-4-yl)methyl ester 5e. 
Starting from compound 1e (0.031 g, 1.1 × 10
-3
 mol) in dry DMF (2 mL), potassium fluoride (0.018 
g, 3.1 × 10
-3
 mol) and N-(tert-butoxycarbonyl)-β-alanine 3 (0.020 g, 1.1 × 10-4 mol), the ester 
conjugate 5c was obtained as a yellow solid (0.011 g, 24%). Mp = 141.2-142.2 ºC. Rf = 0.38 
(dichloromethane / methanol 100:1). 
1
H NMR (CDCl3, 400 MHz): δ = 1.45 (s, 9 H, C(CH3)3), 2.70 
(t, J 6 Hz, 2 H, H-α), 3.47 (t, J 6 Hz, 2 H, H-β), 4.98 (br s, 1 H, NH), 5.33 (s, 2 H, CH2), 6.45 (s, 1 
H, H-3), 7.12 (d, J 16 Hz, 1 H, H-a), 7.25 (d, J 16 Hz, 1 H, H-b), 7.33 (tt, J 7.2 and 1.2 Hz, 1 H, H-
4’), 7.40 (tt, J 7.2 and 1.2 Hz, 2 H, H-3’ and H-5’), 7.45-7.51 (m, 3 H, H-5, H-6 and H-8), 7.43 (dd, 
J 7.2 and 1.2 Hz, 2 H, H-2’ and H-6’) ppm. 13C NMR (CDCl3, 100.6 MHz): δ = 28.30 (C(CH3)3), 
34.51 (C-α), 35.99 (C-β), 61.27 (CH2), 79.59 (C(CH3)3), 112.78 (C-3), 114.60 (C-6), 116.09 (C-4a), 
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122.56 (C-8), 123.59 (C-5), 126.51 (C-a), 126.88 (C-2’ and C-6’), 128.57 (C-4’), 128.80 (C-3’ and 
C-5’), 132.27 (C-b), 136.23 (C-1’), 141.66 (C-7), 148.40 (C-4), 154.12 (C-8a), 155.69 (C=O Boc), 
160.36 (C-2), 171.60 (C=O β-Ala) ppm. IR (liquid film): ν = 3366, 3059, 2976, 2930, 1720, 1610, 
1513, 1450, 1413, 1393, 1367, 1251, 1169, 1082, 1005, 967, 865, 865, 812, 757, 738, 694 cm
-1
. 
HRMS: m/z (ESI): Found [M
+
+1]: 450.19174; C26H28NO6 requires [M
+
+1]: 450.19184. 
 
2.3. General procedure for the synthesis of conjugates 6 and 7. 
A solution of conjugates 4b, 4e, 5b or 5e (12-21 mmol) in dichloromethane/trifluoroacetic 
acid (2:1) (15 mL) was stirred at room temperature during 30 min. The reactional mixture 
was then evaporated to dryness and aqueous 1 M NaOH solution (3 mL) was added and the 
pH adjusted to 7. The mixture was extracted with dichloromethane (3 × 3 mL), the organic 
phase was dried with anhydrous magnesium sulphate, filtered and evaporated to dryness, 
resulting in the required compounds 6b, 6e, 7b or 7e. 
 
2.3.1. Glycine (7-amino-2-oxo-2H-benzopyran-4-yl)methyl ester 6b. Starting from compound 4b 
(0.069 g, 2.0 × 10
-4
 mol), conjugate 6b was obtained as a yellow solid (0.0472 g, 65%). Mp = 
192.0-193.5 ºC. Rf = 0.18 (dichloromethane / methanol 20:1). 
1
H NMR (CD3OD, 400 MHz): δ = 
4.05 (s, 2 H, H-α), 5.47 (s, 2 H, CH2), 6.12 (s, 1 H, H-3), 6,53 (d, J 2 Hz, 1 H, H-8), 6.66 (dd, J 8.8 
and 2 Hz, 1 H, H-6), 7.39 (d, J 8.8 Hz, 1 H, H-5) ppm. 
13
C NMR (CD3OD, 100.6 MHz): δ = 41.00 
(C-α), 63.98 (CH2), 100.67 (C-8), 106.76 (C-3), 107.95 (C-4a), 113.28 (C-6), 126.11 (C-5), 151.64 
(C-4), 154.86 (C-8a), 157.36 (C-7), 164.00 (C-2), 168.27 (C=O Gly) ppm. IR (liquid film):   ν = 
1757, 1672, 1603, 1416, 1332, 1265, 1188, 1127, 882, 838, 800, 748, 720 cm
-1
. HRMS: m/z (ESI): 
Found [M
+
+1]: 249.08759; C12H13N2O4 requires [M
+
+1]: 249.08767. 
 
2.3.2. Glycine (7-styryl-2-oxo-2H-benzopyran-4-yl)methyl ester 6e. Starting from compound 4e 
(0.051 g, 1.2 × 10
-4
 mol), conjugate 6e was obtained as an orange oil (0.0379 g, 66%). Rf = 0.44 
(dichloromethane/methanol 20:1). 
1
H NMR (DMSO-d6, 400 MHz): δ = 3.15 (s, 2 H, H-α), 4.76 (s, 2 
H, CH2), 6.42 (s, 1 H, H-3), 7.28-7.33 (m, 2 H, H-4’and H-a), 7.36-7.41 (m, 4 H, NH2, H-3’and H-
5’), 7.49 (d, 1 H, J 16.8 Hz, H-b), 7.58-7.65 (m, 4 H, H-2’, H-6’, H-6 and H-8), 7.68 (d, J 8 Hz, 1 
H, H-5) ppm. 
13
C NMR (DMSO-d6, 100.6 MHz): δ = 51.70 (C-α), 59.05 (CH2), 110.10 (C-3), 
113.81 (C-6), 116.49 (C-4a), 122.52 (C-8), 124.62 (C-5), 126.81 (C-a), 126.93 (C-2’ and C-6’), 
128.38 (C-4’), 128.85 (C-3’ and C-5’), 131.59 (C-b), 136.55 (C-1’), 140.97 (C-7), 153.50 (C-8a), 
156.38 (C-4), 160.32 (C-2), 171.08 (C=O Gly) ppm. IR (liquid film): ν = 3418, 2925, 2855, 2663, 
2362, 1758, 1681, 1612, 1546, 1433, 1329, 1206, 1134, 1076, 1003, 952, 922.2, 886, 839, 801, 722 
cm
-1
. HRMS: m/z (ESI): Found [M++1]: 336.12364; C20H18NO4 requires [M
+
+1]: 336.12358. 
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2.3.3. β-Alanine (7-amino-2-oxo-2H-benzopyran-4-yl)methyl ester 7b. Starting from compound 5b 
(0.0721 g, 2.1 × 10
-4
 mol), conjugate 7b was obtained as a yellow solid (0.054 g, 67%). Mp = 
201.6-203.0 ºC. Rf = 0.18 (dichloromethane / methanol 20:1) 
1
H NMR (CD3OD, 400 MHz): δ = 
2.93 (t, J 6.4 Hz, 2 H, H-α), 3.33 (t, J 6.4 Hz, 2 H, H-β), 5.47 (s, 2 H, CH2), 6.12 (s, 1 H, H-3), 6.53 
(d, J 2 Hz, 1 H, H-8), 6,66 (dd, J 8.8 and 2 Hz, 1 H, H-6), 7.39 (d, J 8.8 Hz, 1 H, H-5) ppm. 
13
C 
NMR (CD3OD, 100.6 MHz): δ = 32.11 (C-α), 36.26 (C- β), 63.14 (CH2), 100.64 (C-8), 107.21 (C-
3), 108.94 (C-4a), 113.82 (C-6), 126.23 (C-5), 152.25 (C-4), 153.05 (C-8a), 157.23 (C-7), 163.94 
(C-2), 168.27 (C=O β-Ala) ppm. IR (liquid film): ν = 1738, 1680, 1413, 1329, 1202, 1147, 846, 
797, 747, 723 cm
-1
. HRMS: m/z (ESI): Found [M++1]: 263.10325; C13H15N2O4 requires [M
+
+1]: 
263.10327. 
  
2.3.4. β-Alanine (7-styryl-2-oxo-2H-benzopyran-4-yl)methyl ester 7e. Starting from compound 5e 
(0.0551 g, 1.2 × 10
-4
 mol), conjugate 7e was obtained as a yellow solid (0.0403 g, 64%). Mp = 
205.1-206.2 ºC. Rf = 0.44 (dichloromethane/methanol 20:1). 
1
H NMR (DMSO-d6, 400 MHz): δ = 
2.84 (t, J 6.8 Hz, 2 H, H-α), 3.11 (t, J 6.8 Hz, 2 H, H-β), 5.43 (s, 2 H, CH2), 6.47 (s, 1 H, H-3), 7.32-
7.34 (m, 2 H, H-4’and H-a), 7.41 (td, J 6.8 and 2.4 Hz, 2 H, H-3’and H-5’), 7.51 (d, 1 H, J 16.8 Hz, 
H-b), 7.63-7.68 (m, 4 H, H-2’, H-6’, H-6 and H-8), 7.75-7.79 (m, 3 H, H-5 and NH2) ppm. 
13
C 
NMR (DMSO-d6, 100.6 MHz): δ = 31.43 (C-α), 34.64 (C-β), 61.61 (CH2), 111.91 (C-3), 113.91 
(C-6), 115.97 (C-4a), 122.75 (C-8), 125.09 (C-5), 126.78 (C-a), 126.97 (C-2’ and C-6’), 128.50 (C-
4’), 128.87 (C-3’ and C-5’), 131.99 (C-b), 136.46 (C-1’), 141.46 (C-7), 149.70 (C-4), 153.61 (C-
8a), 159.78 (C-2), 169.97 (C=O β-Ala) ppm. IR (liquid film): ν = 1712, 1608, 1452, 1411, 1324, 
1201, 1129, 1070, 1010, 974, 901, 867, 831, 801, 760, 720 cm
-1
. HRMS: m/z (ESI): Found [M++1]: 
350.13930; C21H19N2O5 requires [M
+
+1]: 350.13943. 
 
2.4. General photolysis procedure 
A 110-4 M methanol/HEPES (80:20) solution of compounds 4-7 (mL) were placed in a quartz tube 
and irradiated in a Rayonet RPR-100 reactor at the desired wavelength. The lamps used for 
irradiation were of 254, 300, 350 and 419 ± 10 nm. The HEPES buffer solution was prepared using 
distilled water with HEPES (10 mM), sodium chloride (120 mM), potassium chloride (3 mM), 
calcium chloride (1 mM) and magnesium chloride (1 mM). The pH was adjusted to 7.2 by addition 
of an aqueous solution on sodium hydroxide 6M.   
Aliquots of 100 µL were taken at regular intervals and analysed by RP-HPLC. The eluent was 
acetonitrile / water (3:1) for all the compounds, excepting compounds 4b and 5b (acetonitrile / 
water (1:1) with 0.1% TFA), 6e and 7e (acetonitrile/water (1:1)), at a flow rate of 0.8 mL/min (4b, 
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4e, 5a, 5d, 5e, 6b, 7b), 0.6 mL/min for (4c, 4d, 5b, 5c) and 0.4 mL/min (4a), previously filtered 
through a Millipore, type HN 0.45 µm filter and degassed by ultra-sound for 30 min. The 
chromatograms were traced by detecting UV absorption at the wavelength of maximum absorption 
for each compound (retention time: 4a, 6.3; 5a, 4.2; 4b, 6.4; 5b, 9.3; 4c, 6.3; 5c, 8.8; 4d, 10.6; 5d, 
7.0; 4e, 7.0; 5e, 11.5; 6b: 13.4; 7b: 4.8 min). 
 
3. Results and Discussion 
 
3.1. Synthesis of amino acid conjugates 4-7  
4-(Chloromethyl)-2H-benzopyran-2-one 1a, 7-amino-4-(chloromethyl)-2H-benzopyran-2-one 1b, 
4-(chloromethyl)-7-phenyl-2H-benzopyran-2-one 1c, 4-(chloromethyl)-7-(4’-methoxyphenyl)-2H- 
benzopyran-2-one 1d and 4-(chloromethyl)-7-styryl-2H-benzopyran-2-one 1e were synthesised by 
Pechmann condensations between phenol, ethyl (3-hydroxyphenyl)carbamate, [1,1'-biphenyl]-3-ol, 
4'-methoxy-[1,1'-biphenyl]-3-ol, 3-styrylphenol, respectively, and ethyl 4-chloro-3-oxobutanoate, 
mediated by aqueous sulfuric acid through a known procedure [43], followed by acidolysis (sulfuric 
acid in acetic acid) of ethyl (4-(chloromethyl)-2-oxo-2H-benzopyran-7-yl)carbamate precursor in 
the case of compound 1b (see supporting information). Compounds 1a-e were used in the 
preparation of ester conjugates of glycine and -alanine, as representative models of carboxylic 
acids, by reacting with N-tert-butyloxycarbonylglycine 2 and N-tert-butyloxycarbonyl--alanine 3, 
in the presence of potassium fluoride in DMF at room temperature, yielding cages 4a-e and 5a-e, 
respectively, in 16 to 70% yields. Therefore, in compounds 4b, 4e, 5b and 5e the N-tert-
butyloxycarbonyl protecting group was removed by acidolysis with trifluoroacetic acid in 
dichloromethane giving conjugates 6b, 6e, 7b and 7e bearing the amino acid and the photosensitive 
tag (Scheme 1). 
All compounds were fully characterized by IR, 
1
H and 
13
C NMR spectroscopies. 
1
H NMR spectra 
of conjugates 4-7 showed the amino acid residues, such as the α-CH2 (δ 3.15-4.08 ppm for glycine 
and δ 2.58-2.93 ppm for β-alanine), and -CH2 (δ 3.11-3.47 ppm), in addition to the heterocycle 
methylene group visible for all conjugates (δ 4.76-5.59 ppm). The newly formed ester linkages were 
established by their 
13
C NMR spectra signals of the carbonyl group, at about δ 168.27-171.65 ppm. 
The confirmation of the cleavage of the N-tert-butyloxycarbonyl-protecting group at the amino 
acids was also supported by 
13
C NMR, with the disappearance of spectra signals of the 
corresponding carbonyl group in 6b, 6e, 7b and 7e, which occurred at δ 155.61 or 155.94 ppm in 
conjugates 4b, 4e, 5b and 5e.  The IR spectra of compounds 4-7 displayed stretching vibration 
bands of the ester carbonyl groups from 1712 to 1758 cm
-1
.  
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<Scheme 1> 
 
3.2. Evaluation of the photophysical properties of amino acid conjugates 4-7  
With the aim of finding the parameters required for monitoring the photolytic process, as well as to 
evaluate the effect of the fluorophore structure in different solvents, such as diethyl ether, 
dichloromethane, acetonitrile, dimethyl sulfoxide, methanol and methanol/HEPES buffer (80:20), 
characterization by UV/visible absorption was carried out. Furthermore, fluorescence emission data 
was also collected in methanol and methanol/HEPES buffer (80:20). Degassed 10
-4
 M solutions of 
ester conjugates 4-7 and the corresponding coumarins were measured. The corresponding data: 
absorption (λabs) and emission maxima (λem), molar extinction coefficients (as log ε) and relative 
fluorescence quantum yields (F) are reported in Table 1. Relative fluorescence quantum yields 
were calculated using 9,10-diphenylanthracene in ethanol (F 0.95) [44], with the fluorescence 
standard excited at the maximum absorption wavelength for each compound.  
Concerning the absorption data of conjugates 4-7, variation of the solvent in general did not 
significantly affect the wavelength of maxima absorption; however, as it was expected, the increase 
of the π system extension resulted in a bathochromic shift (λabs 4a < 4c < 4d < 4e and 5a < 5c < 5d 
< 5e). Despite the higher conjugation of systems possessing aromatic substituents at the coumarin 
skeleton (compounds 4c-e and 5c-e), comparatively to the amino group (compounds 4b and 5b) the 
former presented higher λabs in dimethyl sulfoxide, methanol and methanol/HEPES buffer (80:20), 
in the range 353-364 nm. 
 
<Table 1> 
 
To investigate the fluorescence behaviour of the compounds excitation-emission matrices (EEM’s) 
were obtained; with the emission intensity scanned for different excitation wavelengths. The 
outcome for representative compounds (1, 4 and 5; b, d and e - in methanol/ HEPES), showing a 
contour surface of fluorescence intensity for the different excitation / emission wavelengths, are 
given in Figure 1. These fluorescence contour surfaces indicate that the steady state fluorescence 
behaviour of the compounds is quite similar, with an emission maximum close to 480 nm with an 
optimal excitation around 360 nm. 
 
<Figure 1 > 
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3.3. Photolysis studies of amino acid conjugates 4-7 
Comparison of the sensitivity towards UV/visible radiation of glycine and -alanine ester 
conjugates 4-7, bearing different substituents at position 7 of the heterocycle, was carried out by 
exposing solutions of the mentioned compounds in methanol/HEPES buffer (80:20) solution in a 
Rayonet RPR-100 reactor at 254, 300, 350 and 419 nm. The course of the photocleavage reaction 
was followed by reverse phase HPLC with UV detection. The plots of peak area (A) of the starting 
material versus irradiation time were obtained for each compound, at the considered wavelengths. 
Peak areas were determined by HPLC, which revealed a gradual decrease with time, and were the 
average of 3 runs. The determined irradiation time represents the time necessary for the 
consumption of the starting materials until less than 5% of the initial area was detected (Table 2). 
For each compound and based on HPLC data, the plot of ln A versus irradiation time showed a 
linear correlation for the disappearance of the starting material, which suggested a first order 
reaction, obtained by the linear least squares methodology for a straight line. The corresponding rate 
constants were calculated and are presented in Table 2. The photochemical quantum yields (Φphot) 
were calculated based on half-lives (t1/2), extinction coefficient () and the incident photon flux (I0), 
which was determined by potassium ferrioxalate actinometry [45]. The calculated photochemical 
quantum yields indicated that the photocleavage process was not as efficient as desirable, probably 
due to the dissipation of part of the absorbed energy via fluorescence pathways that compete with 
the photochemical reaction. 
 
<Table 2> 
 
It was expected that the bathochromic shift in the maximum absorption wavelengths, related to the 
increase of the  conjugated system due to the presence of aromatic substitution at position 7 of the 
benzopyran, would result in an increase in the efficiency of the photolysis at longer wavelengths, 
leading to shorter irradiation times. The obtained results confirmed this expectation, since 
photocleavage at 350 and 419 nm of conjugates 4e and 5e occurred fast (57 and 109 min at 350 nm; 
318 and 1359 min at 419 nm), in comparison with conjugates 4a, 4c, 4d, 5a, 5c and 5d. 
Furthermore, at these wavelengths the release of N-tert-butyloxycarbonyl glycine 2 and -alanine 3 
required shorter irradiation times than the corresponding free amino acids from cages 6b and 7b. 
Nonetheless, the best results of photolysis obtained at all the wavelengths (254, 300, 350 and 419 
nm) considered in the present study, including at 419 nm were related to conjugates 4b (5-24 min) 
and 5b (7-85 min), possessing the electron donating amino group at position 7 of the heterocycle. 
Although the importance of all the fluorescent caging groups evaluated, the use of 7-amino-4-
(chloromethyl)-2H-benzopyran-2-one 1b is the most feasible for release of the amino acids at 419 
15 
 
nm both for organic synthesis and caging applications, owing to the short irradiation times and 
lowest possible side reactions concerning the functionalities of the molecule. Coumarinyl esters are 
thought to cleave through an ionic mechanism that involves both homolytical or heterolytical 
fission of the O-CH2 bond, although the latter is energetically favoured. The homolytic cleavage of 
the O-C bond, followed by electron transfer, can yield the ion pair (a methylenic coumarin 
carbocation and the leaving group anion), whereas the heterolytic cleavage of the O-C bond directly 
affords the already mentioned ion pair. Once formed, the methylenic coumarin carbocation can 
undergo nucleophilic attack by the solvent to form the final products. The ion pair may also 
recombine to the starting material [46-47]. In our previous work, after irradiation at the various 
wavelengths of irradiation, by NMR monitoring a new set of signals were identified in the aromatic 
region with slight shifts of the signals from those of the starting conjugates, which were in 
agreement with the proposed coumarin by-products, by NMR and mass spectrometry. In recent 
literature and in terms of potential toxicity issues, there are various reports on the use of coumarin 
derivatives in photodelivery applications that have undergone biological validation [48-52]. 
In order to better understand the process, time-resolved fluorescence measurements were made 
exciting at 349 nm, with the emission monitored at 480 nm. The time-resolved decays are shown in 
Figure 2 and in all cases the fluorescence was multi-exponential in nature indicating the presence of 
(at least) two excited states. Compound 1b exhibited a dominant (>90%) decay time of ~5 ns, 
resulting in an average decay time of 4.8 ns. The other b compounds gave average decay times that 
were significantly less (4b, 1.36 ns; 5b, 2.32 ns; 6b, 1.75 ns; 7b, 1.84 ns). This was because of the 
presence of other (non-radiative) decay pathways as expected since the photocleavage of the 
conjugate would be expected to proceed by the production of an ion pair, which would then either 
recombine or lead to the photoproducts. Thus, because of the use of the fluorescent coumarin 
moiety, the time-resolved behaviour can report on this process. The d and e compounds, however, 
did not display any major difference in their relative decay times. Average decay times were; 1d, 
3.2 ns; 4d, 2.99 ns; 5d, 3.12 ns; 1e, 2.12 ns; 4e, 3.09 ns; 5e, 2.81 ns. This may indicate that the 
conjugate is having any significant influence on the photophysical properties of the coumarin 
moiety. During these experiments, it is assumed that any photocleavage of the conjugate is not 
significant. 
To further characterise these compounds the b compounds were selected and from the time-
resolved datasets (decays every 5 nm, spanning 375 nm to 575 nm) decay associated spectra 
determined. This involves a global analysis of the time-resolved decays, linking common decay 
times for all decays, and then plotting the pre-exponential factor for a decay time (weighted by that 
decay time) against wavelength. This helps elucidate both the energy (wavelength) and kinetic of 
the excited states, hence species, present. The results from this form of analysis are presented in 
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Figure 3. The lifetimes obtained are similar to those from the single curves analysis, however the 
presence of a sub-nanosecond contribution is now elucidated. Since these spectra are weighted by 
the decay time they are representative of the contribution to the steady state emission. For 1b the 
emission is dominated by the spectra associated with the longer-lived emission. For 4b, 5b and 7b 
however the major contribution is that between ~1.3 ns to 2.3 ns, although similar in spectral 
appearance. This would indicate that in the latter compounds the decay time has been reduced 
because of the presence of non-radiative decay pathways. For compound 6b the emission is 
dominated by the longer-lived emission, which because of the decay properties of 1b would be 
tempting to attribute to the photocleaved coumarin moiety. Because of the spectral separation it is 
clear that overall at least three different species are present in the conjugated compounds. It would 
be expected that conjugated, ion pair and photocleaved coumarin moiety would be present, with the 
longer-lived decay associated with the photocleaved species and the shortest decay probably 
associated with the conjugated form. 
In addition to the HPLC/UV monitoring of the photolytic release of glycine and -alanine, as the 
expected products of the photolysis, was also followed by 
1
H NMR in a methanol-d4/D2O (80:20) 
solution. This methodology was particularly important for conjugates 6b and 7b, due to difficulties 
in the monitoring by HPLC-UV. NMR monitoring was carried out with 2.50 × 10
-2
 M solutions, 
which led to an expected increase in the photolysis time for the complete release of the molecule, 
when compared to the irradiation times in Table 2 obtained with dilute solutions.  
As representative examples, upon irradiation at 350 nm of solutions of N-(tert-butyloxycarbonyl) 
conjugates of glycine 4b and -alanine 5b and of glycine 6b and β-alanine 7b conjugates, a 
decrease in the intensity of the signals was observed and this was related to the amino acid in the 
conjugates form namely the α-CH2 (δ ≈ 4.00-4.10 ppm, 4b and 6b; δ ≈ 3.30-3.40 ppm, 5b and 7b) 
and β-CH2 (δ ≈ 2.70-3.00 ppm, 5b and 7b), as well as the singlet for the benzylic-type CH2 of the 
heterocycle (δ ≈ 5.40-5.60 ppm). The N-Boc glycine 2 and -alanine 3 released from conjugates 4b 
and 5b, and free glycine or -alanine released from conjugates 6b and 7b, gave rise to a new set of 
signals with the same multiplicity at lower chemical shift, namely α-CH2 (δ ≈ 3.80-3.70 ppm, 4b 
and 6b; δ ≈ 3.30 ppm, 5b and 7b) and β-CH2 (δ ≈ 2.50-2.70 ppm, 5b and 7b) (Figure 4). Based on 
the results obtained by 
1
H NMR, it was possible to corroborate the release of the amino acids from 
these conjugates in methanol/HEPES buffer (80:20) solutions at higher concentrations.  
 
< Figure 4 >  
 
4. Conclusion 
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The comparative photorelease of glycine and -alanine, as representative models of carboxylic acid 
bioactive molecules, from 4-(methylene)-2H-benzopyran-2-one unsubstituted and substituted with 
different substituents at the 7-position of the heterocyclic system, such as amino, phenyl, 4-
methoxyphenyl and styryl groups, under irradiation at variable wavelengths (254, 300, 350 and 419 
nm) was carried out. A remarkable behaviour towards irradiation at higher wavelength (350 and 
419 nm) occurred in conjugates obtained from 4-(chloromethyl)-7-styryl-2H-benzopyran-2-one, 
however the best results were related to 4-(chloromethyl)-7-phenyl-2H-benzopyran-2-one, with 
release of glycine and -alanine in shorter irritation times (ca 8 min at 350 nm; 5 and 85 min, at 419 
nm, respectively), which can be considered in practicable applications. The photolysis observations 
were also complemented by time-resolved fluorescence, which indicated the presence of different 
fluorescing species elucidated by the determination of decay associated spectra. 
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CAPTIONS 
 
Scheme 1. Synthesis of ester cages of glycine and -alanine 4-7. 
 
Table 1: UV-visible data (λabs and log ε) for compounds 1a-e and conjugates 4-7 in diethyl ether, 
dichloromethane, acetonitrile, dimethyl sulfoxide, methanol and methanol/HEPES buffer (80:20). 
 a 
in nm. 
 
Table 2. Irradiation times (tirr in min), rate constants (k, ×10
-2 
min
-1
) and
 
photochemical quantum 
yields (ΦP,  10
-3
) for the photolysis of conjugates 4-7 at 254, 300, 350 and 419 nm in 
methanol/HEPES buffer (80:20) solution  
 
Figure 1. EEMs for selected compounds in methanol/ HEPES. The relative intensity is shown in a 
rainbow colour scale with red most intense, blue (black) least intense. The excitation wavelengths 
are plotted on the y-axis, with emission on the x-axis. 
 
Figure 2. Time-resolved fluorescence decays for selected compounds in methanol/ HEPES. The 
compounds were excited at 349 nm with the emission monitored at 480 nm. 
 
Figure 3. Decay associated spectra for selected compounds in methanol/ HEPES. The excitation 
wavelength was 349 nm. 
 
Figure 4. Partial 
1
H NMR spectra in methanol-d4/D2O (80:20) of the photolysis at 350 nm of 2.50 × 
10
-2
 M solutions of N-Boc conjugates of glycine 4b and -alanine 5b: a) before irradiation; b) after 
irradiation for 90 min; and c) after irradiation for 150 min; and glycine conjugate 6b and -alanine 
conjugate 7b: a) before irradiation; b) after irradiation for 150 min; and c) after irradiation for 270 
min. 
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SCHEMES 
Scheme 1 
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TABLES 
 
Table 1 
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Cpd 
Diethyl ether Dichloromethane Acetonitrile Dimethyl sulfoxide Methanol 
Methanol/HEPES 
buffer (80:20) 
λabs
a
 log ε λabs
a
 log ε λabs
a
 log ε λabs
a
 log ε λabs
a
 log ε λabs
a
 log ε 
1a 310 3.50 314 3.34 308 3.37 316 3.29 310 3.43 310 3.29 
1b 346 4.14 347 4.19 350 4.18 365 4.23 361 4.21 357 3.98 
1c 327 4.14 331 4.01 324 4.05 325 3.97 327 4.09 329 4.13 
1b 335 4.12 342 4.09 338 4.11 343 4.16 339 4.23 342 4.14 
1e 349 4.21 356 4.13 349 4.06 358 4.00 352 4.15 353 4.18 
4a 299 3.72 314 3.59 310 3.67 312 3.66 309 3.69 305 3.52 
4b 341 4.24 343 4.13 348 4.11 364 4.11 353 4.20 353 4.18 
4c 326 4.13 329 4.02 323 4.00 326 4.03 326 4.11 323 4.08 
4d 329 4.03 338 3.99 332 4.00 336 4.06 337 4.04 335 3.91 
4e 345 4.09 354 4.05 348 4.02 353 3.90 348 3.97 352 3.98 
5a 305 3.69 314 3.53 310 3.6 310 3.51 308 3.66 308 3.54 
5b 341 4.19 342 4.06 348 4.11 362 4.17 356 4.12 356 4.14 
5c 324 4.23 328 4.07 323 4.00 326 4.17 326 4.11 323 4.08 
5d 336 4.22 339 4.20 335 4.22 338 4.20 336 4.25 340 4.11 
5e 347 4.30 354 4.33 348 4.16 353 4.17 350 4.24 354 4.17 
6b 335 2.76 335 2.60 345 3.65 356 4.00 356 4.01 361 4.05 
6e 333 3.13 338 3.36 335 3.61 342 3.69 341 3.61 347 3.83 
7b 333 2.52 336 2.67 347 3.91 355 3.95 356 3.97 361 4.01 
7e 344 2.72 353 3.68 349 4.10 351 4.24 352 4.27 354 4.25 
26 
 
Table 2 
a
 No cleavage was detected up to 8h of irradiation. 
 
Cpd 
254 nm 300 nm 350 nm 419 nm 
tirr k phot tirr k phot tirr k phot tirr k phot 
4a 77 3.9 0.41 83 3.6 0.18 - 
a
 - 
a
 - 
a
 - 
a
 - 
a
 - 
a
 
4b 12 23.7 0.63 24 12.5 0.15 8 36.3 0.41 4.9 5.3 0.06 
4c 47 6.7 0.17 128 2.4 0.03 421 0.8 0.005 1610 0.2 0.003 
4d 105 2.8 0.08 189 1.6 0.04 268 1.1 0.03 382 0.8 0.02 
4e 83 3.6 0.14 110 2.7 0.05 57 4.9 0.13 318 0.8 0.02 
5a 84 3.6 0.37 80 3.7 0.19 - 
a
 - 
a
 - 
a
 - 
a
 - 
a
 - 
a
 
5b 15 19.7 0.54 16 18.0 0.30 7 42.8 0.60 85 3.4 0.05 
5c 248 1.3 0.03 137 2.2 0.03 421 0.8 0.007 14945 0.02 0.0002 
5d 887 0.3 0.009 3778 0.08 0.001 - 
a
 - 
a
 - 
a
 - 
a
 - 
a
 - 
a
 
5e 175 1.8 0.04 178 1.7 0.02 109 2.7 0.03 1359 0.2 0.003 
6b 100 3.2 0.05 73 4.2 0.03 71 4.3 0.04 - 
a
 - 
a
 - 
a
 
7b 171 1.8 0.03 114 2.6 0.03 123 2.4 0.03 775 0.38 0.004 
27 
 
FIGURES 
 
Figure 1 
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Figure 2 
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Figure 3 
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Figure 4  
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SUPPORTING INFORMATION 
 
 
Scheme 1: Synthesis of phototriggers 1a-e.  
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1. Synthesis of phototriggers 1a-e 
1.1. Synthesis of 4-(chloromethyl)-2H-benzopyran-2-one 1a. A solution of phenol (0.151 g, 1.6×10
-2 
mol) and ethyl 4-chloro-3-oxobutanoate (0.43 mL, 3.2 ×10
-2 
mol) in 70% aqueous sulfuric acid (10 
mL) was stirred at room temperature during 4 days, and followed by TLC (ethyl acetate/light 
petroleum 1:1).  The reactional mixture was poured into water and extracted with ethyl acetate; the 
organic phase was dried with anhydrous magnesium sulfate and evaporated. The dark pink oil was 
purified by column chromatography using dichloromethane as eluent, giving compound 1a as white 
crystals (0.053 g, 17%). Mp = 135-135.4 ºC. 
1
H NMR (CDCl3, 400 MHz): δ = 4.69 (s, 2 H, CH2Cl), 
6.59 (s, 1 H, H-3), 7.35 (dt, J 7.2 and 1.2 Hz, 1 H, H-6), 7.39 (dd, J 8.4 and 0.8 Hz, 1 H, H-8), 7.58 
(dt, J 7.2 and 1.6 Hz, 1 H, H-7), 7.68 (dd, J 8 and 1.6 Hz, 1 H, H-5) ppm. 
13
C NMR (CDCl3, 100.6 
MHz): δ = 41.20 (CH2Cl), 115.94 (C-3), 117.27 (C-4a), 117.48 (C-8), 124.11 (C-5), 124.50 (C-6), 
132.27 (C-7), 149.43 (C-4), 153.83 (C-8a), 160.19 (C-2) ppm. IR (liquid film): ν = 3415, 3085, 
2964, 1735, 1608, 1564, 1448, 1390, 1260, 1186, 1159, 1087, 957, 918, 898, 854, 803, 774, 
753,733, 620 cm
-1
. 
 
1.2. Synthesis of 7-amino-4-(chloromethyl)-2H-benzopyran-2-one 1b. Ethyl (4-(chloromethyl)-2-
oxo-2H-benzopyran-7-yl)-carbamate (0.258 g, 9.2 × 10
-4 
mol) was refluxed for 1.5 h in a mixture of 
concentrated sulfuric acid and glacial acetic acid (1:1; 8 mL). The reaction was followed by TLC 
(ethyl acetate/light petroleum 1:1), and when completed, the orange mixture was poured into ice 
cold water (50 mL). An aqueous solution of 6 M sodium hydroxide was added until pH was 
approximately 5. A solid was precipitated and filtered giving compound 1b as yellow solid (0.187 
g, 98%). Mp = 219.2-220 ºC. Rf = 0.31 (ethyl acetate / light petroleum, 1:1). 
1
H NMR (DMSO-d6, 
400 MHz): δ = 4.85 (s, 2 H, CH2Cl), 6.17 (s, 1 H, H-3), 6.43 (d, J 2.4 Hz, 1 H, H-8), 6.58 (dd, J 8.4 
and 2.4 Hz, 1 H, H-6), 7.47 (d, J 8.8 Hz, 1 H, H-5) ppm. 
13
C NMR (DMSO-d6, 100.6 MHz): δ = 
41.43 (CH2Cl), 98.68 (C-8), 106.11 (C-4a), 107.87 (C-3), 111.32 (C-6), 126.11 (C-5), 151.28 (C-4), 
153.37 (C-7), 155.95 (C-8a), 160.66 (C-2) ppm. IR (KBr 1%): ν = 3418, 2255, 2129, 1655, 1238, 
1048, 1026, 1002, 825, 764 cm
-1
.  
 
Synthesis of ethyl (4-(chloromethyl)-2-oxo-2H-benzopyran-7-yl)-carbamate. Ethyl (3-
hydroxyphenyl)carbamate (0.335 g, 1.85 × 10
-4
 mol) and ethyl 4-chloro-3-oxobutanoate (1.07 mL, 
1.0 × 10
-2
 mol) were dissolved in 70% ethanolic sulfuric acid (5 mL). The reaction mixture was 
followed by TLC (ethyl acetate/light petroleum 1:1) and stirred at room temperature for 3 days. 
When the reaction was completed, the mixture was poured into water and extracted with ethyl 
acetate. The organic phase was dried with anhydrous magnesium sulphate and evaporated, 
obtaining a mixture of an orange oil and beige solid which was washed with ethyl acetate. The solid 
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was filtrated resulting compound 3 as a beige solid (0.258 g, 50%).   Mp = 182.7-183.4 ºC. Rf = 
0.62 (ethyl acetate/light petroleum 1:1). 
1
H NMR (DMSO-d6, 400 MHz): 1.25 (t, J 7.2 Hz, 3 H, 
CH2CH3), 4.16 (q, J 7.2 Hz, 2 H, CH2CH3), 4.96 (s, 2 H, CH2Cl), 6.50 (s, 1 H, H-3), 7.41 (dd, J 8.8 
and 2.4 Hz, 1 H, H-6), 7.72 (d, J 2 Hz, 1 H, H-8), 7.75 (d, J 8.8 Hz, 1 H, H-5), 10.18 (s, 1 H, NH) 
ppm. 
13
C NMR (DMSO-d6, 100.6 MHz): δ = 14.37 (CH2CH3), 41.20 (CH2Cl), 60.76 (CH2CH3), 
104.61 (C-8), 111.60 (C-4a), 112.67 (C-3), 114.32 (C-6), 125.88 (C-5), 143.18 (C-7), 150.63 (C-4), 
153.31 (C=O carbamate), 154.28 (C-8a), 159.90 (C-2) ppm. IR (KBr 1%,): ν = 3287, 3087, 2983, 
1710, 1622, 1594, 1530, 1476, 1415, 1386, 1366, 1335, 1287, 1240, 1172, 1080, 1042, 1017, 985, 
921, 886, 863, 850, 819, 766 cm
-1
. 
 
Synthesis of ethyl (3-hydroxyphenyl)carbamate. 3-Aminophenol (0.39 g, 3.0 × 10
-3
 mol) and ethyl 
chloroformate (0.74 mL, 6 × 10
-3
 mol) were dissolved in diethyl ether (40 mL). The reaction 
mixture was stirred at room temperature for 29 hours and followed by TLC (dichloromethane). The 
white solid was filtered and the filtrate was evaporated with the required compound obtained as 
beige crystals (0.344 g, 63%). 
1
H NMR (DMSO-d6, 400 MHz): δ = 1.22 (t, J 7.2 Hz, 3 H, 
CH2CH3), 4.08 (q, J 7.2 Hz, 2 H, CH2CH3), 6.36 (dd, J 8.1 and 2.4 Hz, 1 H, H-4), 6.82 (dd, J 8.1 
and 2.4 Hz, 1 H, H-6), 6.97-6.99 (m, 1 H, H-2), 7.00 (t, J 8.1 Hz, 1 H, H-5), 9.30 (s, 1 H, OH), 9.45 
(s, 1 H, NH) ppm. IR (liquid film): ν = 3415, 3085, 2964, 1735, 1608, 1564, 1448, 1390, 1260, 
1186, 1159, 1087, 957, 918, 898, 854, 803, 774, 753, 733, 620 cm
-1
. 
 
1.3. Synthesis of 4-(chloromethyl)-7-phenyl-2H-benzopyran-2-one 1c. A suspension of [1,1’-
byphenyl]-3-ol (0.163 g, 9.0 × 10
-4
 mol) and ethyl 4-chloro-3-oxobutanoate (0.259 mL, 1.9 × 10
-3
 
mol) in 70% aqueous sulfuric acid (10 mL) was stirred at 40 ºC during 3 days and the reaction 
followed by TLC (dichloromethane). The reactional mixture was extracted with ethyl acetate, dried 
with anhydrous magnesium sulphate and evaporated, resulting in brown oil. After purification by 
column chromatography using light petroleum/ethyl acetate (mixtures of increasing polarity) as 
eluent, compound 1c was obtained as a brown solid (0.080 g, 31%). Mp = 132.1-133.3 ºC. Rf = 0.7 
(dichloromethane). 
1
H NMR (CDCl3, 400 MHz): δ = 4.70 (s, 1 H, CH2Cl), 6.57 (s, 1 H, H-3), 7.43 
(tt, 7.2 and 2 Hz, 1 H, H-4’), 7.49 (td, J 7.2 and 2 Hz, 2 H, H-3’ and H-5’), 7.56-7.59 (m, 2 H, H-6 
and H-8), 7.63 (dt, J 7.2 and 2 Hz, 2 H, H-2’and H-6’), 7.72 (d, J 8.4 Hz, 1 H, H-5) ppm. 13C NMR 
(CDCl3, 100.6 MHz): δ = 41.18 (CH2Cl), 115.38 (C-3), 115.42 (C-6), 116.11 (C-4a), 123.25 (C-8), 
124.46 (C-5), 127.12 (C-2’ and C-6’), 128.66 (C-4’), 129.08 (C-3’ and C-5’), 138.70 (C-1’), 145.34 
(C-7), 149.27 (C-4), 154.21 (C-8a), 160.28 (C-2) ppm. IR (liquid film): ν = 2985, 2945, 1722, 1618, 
1160, 962, 933, 874, 862, 817, 758, 693 cm
-1
.       
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Synthesis of [1,1’-biphenyl]-3-ol. A solution of bromobenzene (0.102 mL, 9.0 × 10-4 mol), (3-
hydroxyphenyl)boronic acid (0.158 g, 1.15 × 10
-3
 mol), bis(triphenylphosphine)palladium (II) 
dichloride (0.013 g, 1.9 × 10
-5
 mol) and potassium carbonate (0.264 g, 1.9 × 10
-3
 mol) in ethanol / 
water (5:1) (11 mL) was stirred at room temperature. The reactional mixture was kept under these 
conditions during 5 days and followed by TLC (dichloromethane). The mixture was diluted in ethyl 
acetate, filtrated in a layer of celite over silica gel and the filtrate was evaporated. After purification 
by column chromatography using dichloromethane as eluent, the required compound was obtained 
as a white solid (0.126 g, 77%). Mp = 56-58 ºC. Rf = 0.73 (dichloromethane). 
1
H NMR (CDCl3, 400 
MHz): δ = 4.78 (br s, 1 H, OH), 6.87 (ddd, J 8, 2.4 and 1 Hz, 1 H, H-4), 7.11 (t, J 2.4 Hz, 1 H, H-2), 
7.22 (dt, J 7.6 and 2.4 Hz, H-6), 7.32-7.41 (m, 2 H, H-5 and H4’), 7.46 (tt, J 6.6 and 1 Hz, 2 H, H-
3’and H-5’), 7.60 (dt, J 6.6 and 1 Hz, 2 H, H-2’and H-6’) ppm. 13C NMR (CDCl3, 100.6 MHz): δ = 
114.08 (C-2), 114.20 (C-4), 119.77 (C-6), 127.06 (C-2’ and C-6’), 127.45 (C-4’), 128.71 (C-3’and 
C-5’), 129.97 (C-5), 140.64 (C-1’), 142.96 (C-1), 155.70 (C-3) ppm. IR (liquid film): ν = 3434, 
1703, 1596, 1452, 1364, 1230, 1156, 1077, 966, 783, 693 cm
-1
. 
 
1.4. Synthesis of 4-(chloromethyl)-7-(4-methoxyphenyl)-2H-benzopyran-2-one 1d. A suspension of 
4’-methoxy-[1,1’-byphenyl]-3-ol (0.185 g, 9.0 × 10-4 mol) and ethyl 4-chloro-3-oxobutanoate 
(0.248 mL, 1.8 × 10
-3
 mol) in 70% aqueous sulfuric acid (10 mL) was stirred at 40 ºC, during 3 
days, and followed by TLC (dichloromethane). The reactional mixture was extracted with ethyl 
acetate, dried with anhydrous magnesium sulphate and evaporated, resulting in a mixture of dark 
pink oil. After purification by column chromatography using petroleum ether/ethyl acetate 
(mixtures of increasing polarity) as eluent, compound 1d was obtained as a beige solid (0.10 g, 
35%). Mp = 113.3-114.2 ºC. Rf = 0.5 (dichloromethane). 
1
H NMR (CDCl3, 400 MHz): δ = 3.87 (s, 
3 H, OCH3), 4.96 (s, 2 H, CH2Cl), 6.62 (s, 1 H, H-3), 7.01 (dt, J 8.8 and 2 Hz, 2 H, H-3’ and H-5’), 
7.47-7.58 (m, 5 H, H-5, H-6, H-8, H-2’ and H-6’) ppm. 13C NMR (CDCl3, 100.6 MHz): δ = 55.40 
(OCH3), 60.78 (CH2Cl), 111.32 (C-3), 114.53 (C-3’ and C-5’), 114.61 (C-6), 115.73 (C-4a), 122.64 
(C-8), 123.63 (C-5), 128.28 (C-2’ and C-6’), 131.30 (C-1’), 144.57 (C-7), 153.91 (C-4), 154.06 (C-
8a), 160.16 (C-4’), 161.33 (C-2) ppm. IR (liquid film): ν = 2985, 2326, 1722, 1608, 1525, 1498, 
1398, 1280, 1252, 1181, 1028, 962, 874, 821, 736 cm
-1
.      
 
Synthesis of 4’-methoxy-[1,1’-biphenyl]-3-ol. A solution of 4-methoxy-bromobenzene (0.94 mL, 
7.5 × 10
-4
 mol), (3-hydroxyphenyl)boronic acid (0.124 g, 9.0 × 10
-4
 mol), 
bis(triphenylphosphine)palladium (II) dichloride (0.011 g, 1.5 × 10
-5
 mol) and potassium carbonate 
(0.207 g, 1.5 × 10
-3
 mol) in ethanol / water (5:1) (11 mL) was stirred at room temperature. The 
reactional mixture was kept under these conditions during 5 days and followed by TLC 
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(dichloromethane). The mixture was diluted in ethyl acetate, filtrated in a layer of celite over silica 
gel and the filtrate was evaporated. After purification by column chromatography using 
dichloromethane as eluent, the required compound was obtained as a white solid (0.109 g, 72%). 
Mp = 101.1-102.5 ºC. Rf = 0.5 (dichloromethane). 
1
H NMR (CDCl3, 400 MHz): δ = 3.87 (s, 3 H, 
OCH3), 5.31 (br s, 1 H, OH), 6.82 (ddd, J 8, 2.4 and 1 Hz, 1 H, H-4), 6.98 (dt, 8.4 and 2.6 Hz, 2 H, 
H-3’and H-5’), 7.05 (t, J 2.4 Hz, 1 H, H-2), 7.15 (dt, J 8 and 1 Hz, 1 H, H-6), 7.30 (t, J 8 Hz, 1 H, 
H-5), 7.51 (dt, J 8.4 and 2.4 Hz, 1 H, H-2’ and H-6’) ppm. 13C NMR (CDCl3, 100.6 MHz): δ = 
55.33 (OCH3), 113.4 (C-2 and C-4), 114.17 (C-3’ and C-5’), 119.17 (C-6), 128.07 (C-2’ and C-6’), 
129.91 (C-5), 133.29 (C-1’), 142.47 (C-1), 155.89 (C-3), 159.11 (C-4’) ppm. IR (dichloromethane): 
ν = 3440, 2088, 1700, 1639, 1477, 1431, 1364, 1305, 1203, 1088, 883, 758, 698 cm-1.  
 
1.5. Synthesis of 4-(chloromethyl)-7-styril-2H-benzopyran-2-one 1e. A suspension of 3-styrilphenol   
(0.165 g, 8.3 × 10
-4
 mol) and ethyl 4-chloro-3-oxobutanoate (0.224 mL, 1.6 × 10
-3
 mol) in 70% 
aqueous sulfuric acid (10 mL) was stirred at 40 ºC during 4 days and followed by TLC 
(dichloromethane). The reactional mixture was extracted with ethyl acetate, dried with anhydrous 
magnesium sulphate and evaporated, resulting in brown oil. After purification by column 
chromatography using light petroleum/ethyl acetate (mixtures of increasing polarity) as eluent, 
compound 1e was obtained as a yellow solid (0.070 g, 28%). Mp = 136.6-137.3 ºC. Rf = 0.67 
(dichloromethane). 
1
H NMR (CDCl3, 400 MHz): δ = 4.68 (s, 2 H, CH2Cl), 6.54 (s, 1 H, H-3), 7.13 
(d, J 16.4 Hz, 1 H, H-a), 7.23 (d, J 16.4 Hz, 1 H, H-b), 7.33 (tt, J 7.2 and 2 Hz, 1 H, H-4’), 7.407 (t, 
J 7,2 Hz, 2 H, H-3’and H-5’), 7.47-7.51 (m, 2 H, H-6 and H-8), 7.57 (d, J 7.2 Hz, 2 H, H-2’ and H-
6’), 7.65 (d, J 8 Hz, 1 H, H-5) ppm. 13C NMR (CDCl3, 100.6 MHz): δ = 41.22 (CH2Cl), 114.68 (C-
6), 115.12 (C-3), 116.37 (C-4a), 122.59 (C-8), 124.37 (C-5), 126.57 (C-a), 126.94 (C-2’ and C-6’), 
128.63 (C-4’), 128.85 (C-3’ and C-5’), 132.38 (C-b), 136.28 (C-1’), 141.82 (C-7), 149.22 (C-4), 
154.37 (8a), 160.37 (C-2) ppm. IR (dichloromethane): ν = 3420, 2963, 2925, 2855, 1724, 1609, 
1546, 1495, 1449, 1414, 1398, 1276, 1263, 1217, 1145, 1083, 1020, 963, 862, 804, 737, 695 cm
-1
.      
 
Synthesis of 3-styrylphenol. A solution of (2-bromovinyl)benzene (0.096 mL, 7.5 × 10
-4
 mol), (3-
hydroxyphenyl)boronic acid (0.124 g, 9.0 × 10
-4
 mol), bis(triphenylphosphine)palladium (II) 
dichloride (0.0105 g, 1.5 × 10
-5
 mol) and potassium carbonate (0.2073 g, 1.5 × 10
-3
 mol) in ethanol / 
water (5:1) (11 mL) was stirred at room temperature. The reactional mixture was kept under these 
conditions during 5 days and followed by TLC (dichloromethane). The mixture was diluted in ethyl 
acetate, filtrated in a layer of celite over silica gel and the filtrate was evaporated. After purification 
by column chromatography using dichloromethane as eluent, the required compound was obtained 
as a white solid (0.073 g, 50%). Mp = 111.6-113.1 ºC. Rf = 0.6 (dichloromethane). 
1
H NMR 
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(CDCl3, 400 MHz): δ = 6.78 (ddd, J 8.4, 2.2 and 1.2 Hz, 1 H, H-6), 7.01 (t, J 2 Hz, 1 H, H-2), 7.04-
7.13 (m, 3 H, H-a, H-b and H-4), 7.23-7.30 (m, 2 H, H-5 and H-4’), 7.38 (td, J 7.2 and 1.2 Hz, 2 H, 
H-3’and H-5’), 7.52 (dt, J 7.2 and 1.2 Hz, 2 H, H-2’and H-6’) ppm. 13C NMR (CDCl3, 100.6 MHz): 
δ = 112.96 (C-2), 114.68 (C-6), 119.46 (C-4), 126.54 (C-2’and C-6’), 127.70 (C-4’), 128.20 (C-a), 
128.66 (C-3’ and C-5’), 129.17 (C-b), 129.86 (C-5), 137.10 (C-1’), 139.07 (C-3), 155.70 (C-1) 
ppm. IR (dichloromethane): ν = 3411, 1700, 1597, 1477, 1430, 1364, 1305, 1202, 884, 758, 698 cm
-
1
.  
 
